Baxter
Baxter International Inc. is a global healthcare company that develops, manufactures, and markets medical products including intravenous solutions, infusion systems, renal care and dialysis products, pharmaceuticals, and surgical care devices for hospitals, clinics, and home-care patients. It serves healthcare providers, governments, and patients worldwide through direct sales and distribution partnerships. The company generates revenue by selling its medical devices, consumables, and related therapies, as well as associated services and support programs.
- Revenue
- $1B+
- Employees
- 5,001+
- Founded
- 1931
- Headquarters
- Deerfield, United States of America
Baxter customers on Arbolus
Customers who reviewed Baxter
Seniority of Baxter customers
Most people who reviewed Baxter hold C-Suite roles (52%), followed by Director (32%) and Manager (15%).
- C-Suite 52%
- Director 32%
- Manager 15%
Customers sample
Employer names and spend open in the full report, along with the other 38 customers.
What 41 Arbolus experts think of Baxter
Overall sentiment: Positive
NPS scores are skewed highly positive, with about 60% reporting scores of 8 or above and strong renewal intent among influencers and high spenders. Most experts report being in implementation for over a year, indicating high stickiness. Key feedback themes include superior hemostatic efficacy, operational convenience, and robust bundled offerings, offset by some concerns about preparation timing and storage requirements.
Everything 41 customers told us about Baxter.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
26 Net Promoter Score, from 41 scored reviews- Promoters 18
- Passives 16
- Detractors 7
Praised
- Market-Leading Clinical Performance
- Clinical Outcome Impact
- Bundled Offerings Across Hospital Needs
- Expand Cost-Effective Bundles
Criticised
- Competitor Innovation Risk
- Storage and Supply Chain Complexity
- Cost-Pressure Switching Risk
- High Unit Costs
What Baxter customers say
Market-Leading Clinical Performance
“I view Baxter as a leader for intraoperative hemostasis and tissue sealing, especially in complex surgical cases where rapid bleeding control is critical.”
Clinical Outcome Impact
“By using Baxter’s FLOSEAL in complex joint surgeries, we achieve rapid bleeding control and significantly lower our blood transfusion rates post-op.”
Bundled Offerings Across Hospital Needs
“Combining high-value bio-pharmaceuticals with essential IV and irrigation fluids lets us secure negotiated pricing across multiple departments.”
Renewal intent
Plan to renew 63%Plan to renew, by seniority
- 50% 8 answers
- 75% 8 answers
- 8.7/10 Average score from customers who will renew
- 7.2/10 Average score from undecided customers
- 0/10 Average score from customers not renewing
Top alternatives
Most weighed by Baxter customersReport
For people who use Baxter
Do you use Baxter at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 41 customers of Baxter have already contributed
Takes a few minutes. Your identity stays anonymous.